Skip to content
sellWeak10b5-1 plan

Rosty Raykov sold $63k of FENC

director at FENNEC PHARMACEUTICALS INC.. 10,000 shares at an average of $6.31, traded May 5, 2025, filed May 5, 2025.

Warning score
8
Value
$63k
10,000 shares
Holdings after
53,587
-16% from before
From 52-week low
+57%
low $3.99, close $6.28
From 52-week high
-11%
high $7.02, as of May 5, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $63k at market
    +8
  • Share of holdings sold
    Sold 16% of holdings
    +5
  • Cluster
    No other insider selling within 14 days
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +22.2%, 3m +32.5%, 6m +29.5%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

FENCOct 9, 2026 · close 10.71
Since filing May 5, 2025: +70.5%SPY +40.5% · excess +30.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001415889-25-012016, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 5, 2025SOpen-market sale
Common shares10b5-1
-10,000$6.31$63k53,587May 5, 2025

Related signals

Other insiders at FENNEC PHARMACEUTICALS INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
19Weak
FENCsell 210b5-1
FENNEC PHARMACEUTICALS INC.
Marco Maria Brughera
director
$160k
15,545 shares
-100%
13Weak
FENCsell 410b5-1
FENNEC PHARMACEUTICALS INC.
Rosty Raykov
other
$121k
10,000 shares
-7%
61Notable
FENCsell 3
FENNEC PHARMACEUTICALS INC.
Pierre Sargis Sayad
Chief Medical Officer
$146k
12,000 shares
-56%
35Weak
FENCsell 310b5-1
FENNEC PHARMACEUTICALS INC.
Robert Andrade
CHIEF FINANCIAL OFFICER
$884k
75,000 shares
-26%
0Weak
FENCsell10b5-1
FENNEC PHARMACEUTICALS INC.
Rosty Raykov
other
$96k
10,000 shares
-7%
0Weak
FENCsell10b5-1
FENNEC PHARMACEUTICALS INC.
Rosty Raykov
other
$100k
9,599 shares
-6%
0Weak
FENCsell10b5-1
FENNEC PHARMACEUTICALS INC.
Rosty Raykov
director
$94k
9,747 shares
-7%
0Weak
FENCsell 210b5-1
FENNEC PHARMACEUTICALS INC.
Chris A Rallis
director
$59k
8,346 shares
-12%
0Weak
FENCsell 210b5-1
FENNEC PHARMACEUTICALS INC.
Rosty Raykov
director
$70k
10,781 shares
-8%
0Weak
FENCsell10b5-1
FENNEC PHARMACEUTICALS INC.
Rosty Raykov
director
$69k
10,946 shares
-9%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Rosty Raykov sold $63k of FENC | InsiderTell